Nicole A. Aqui

6.2k total citations · 4 hit papers
41 papers, 3.4k citations indexed

About

Nicole A. Aqui is a scholar working on Oncology, Immunology and Hematology. According to data from OpenAlex, Nicole A. Aqui has authored 41 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Immunology and 15 papers in Hematology. Recurrent topics in Nicole A. Aqui's work include CAR-T cell therapy research (13 papers), Lymphoma Diagnosis and Treatment (11 papers) and Complement system in diseases (10 papers). Nicole A. Aqui is often cited by papers focused on CAR-T cell therapy research (13 papers), Lymphoma Diagnosis and Treatment (11 papers) and Complement system in diseases (10 papers). Nicole A. Aqui collaborates with scholars based in United States, Austria and Germany. Nicole A. Aqui's co-authors include Nancy M. Dunbar, Laura Connelly‐Smith, Volker Witt, Yanyun Wu, Rasheed A. Balogun, Anand Padmanabhan, Huy P. Pham, Jennifer Schneiderman, Reinhard Klingel and Nicole D. Zantek and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Nicole A. Aqui

40 papers receiving 3.4k citations

Hit Papers

Guidelines on the Use of Therapeutic Apheresis in Clinica... 2016 2026 2019 2022 2019 2016 2016 2023 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
    2019 1.1k citations Anand Padmanabhan, Laura Connelly‐Smith et al. Journal of Clinical Apheresis profile →
  2. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice–Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue
    2016 544 citations Joseph E. Schwartz, Anand Padmanabhan et al. Journal of Clinical Apheresis profile →
  3. 临床实践中治疗性单采术应用指南——基于美国血浆置换学会编写委员会的循证策略：第七版
    2016 388 citations Joseph E. Schwartz, Anand Padmanabhan et al. Journal of Clinical Apheresis profile →
  4. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue
    2023 199 citations Laura Connelly‐Smith, Nicole A. Aqui et al. Journal of Clinical Apheresis profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicole A. Aqui United States 18 1.3k 867 862 569 452 41 3.4k
Volker Witt Austria 21 967 0.7× 523 0.6× 1.0k 1.2× 598 1.1× 456 1.0× 61 3.4k
Jan‐Stephan Sanders Netherlands 34 875 0.7× 848 1.0× 1.8k 2.0× 802 1.4× 508 1.1× 168 4.2k
O. Fain France 37 888 0.7× 430 0.5× 815 0.9× 978 1.7× 413 0.9× 203 4.2k
A. Mékinian France 38 1.1k 0.9× 365 0.4× 626 0.7× 552 1.0× 395 0.9× 231 4.4k
Maria Greenwald United States 30 1.5k 1.1× 1.2k 1.4× 1.2k 1.3× 868 1.5× 328 0.7× 76 5.1k
Rob Fijnheer Netherlands 40 1.2k 0.9× 267 0.3× 1.6k 1.9× 590 1.0× 405 0.9× 137 4.4k
Sonata Jodele United States 42 2.5k 1.9× 879 1.0× 1.7k 2.0× 515 0.9× 540 1.2× 171 5.1k
Elliot Chartash United States 23 1.4k 1.1× 792 0.9× 1.5k 1.7× 601 1.1× 224 0.5× 49 4.7k
Laura Connelly‐Smith United States 12 784 0.6× 256 0.3× 940 1.1× 544 1.0× 425 0.9× 32 2.6k
Kenneth Kalunian United States 46 4.5k 3.5× 1.1k 1.2× 683 0.8× 518 0.9× 464 1.0× 156 8.2k

Countries citing papers authored by Nicole A. Aqui

Since Specialization
Citations

This map shows the geographic impact of Nicole A. Aqui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicole A. Aqui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicole A. Aqui more than expected).

Fields of papers citing papers by Nicole A. Aqui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicole A. Aqui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicole A. Aqui. The network helps show where Nicole A. Aqui may publish in the future.

Co-authorship network of co-authors of Nicole A. Aqui

This figure shows the co-authorship network connecting the top 25 collaborators of Nicole A. Aqui. A scholar is included among the top collaborators of Nicole A. Aqui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicole A. Aqui. Nicole A. Aqui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, E. S., et al.. (2024). Therapeutic Plasma Exchange for the Symptomatic Treatment of Scleromyxedema: A Case Report and Literature Review. Journal of Clinical Apheresis. 39(6). e22153–e22153.
2.
Tanhehco, Yvette C., Vijay Bhoj, Andrew D. Fesnak, et al.. (2023). Red cell exchange for rapid leukoreduction in adults with hyperleukocytosis and leukostasis. Blood. 143(11). 1049–1054. 1 indexed citations
3.
Liu, Hien, Leon Su, Jeffrey L. Winters, et al.. (2022). Considerations for immune effector cell therapy collections: a white paper from the American Society for Apheresis. Cytotherapy. 24(9). 916–922. 5 indexed citations
4.
Thibodeaux, Suzanne R., Nicole A. Aqui, Yara A. Park, et al.. (2022). Lack of defined apheresis collection criteria in publicly available CAR‐T cell clinical trial descriptions: Comprehensive review of over 600 studies. Journal of Clinical Apheresis. 37(3). 223–236. 10 indexed citations
5.
Balogun, Rasheed A., Amber P. Sanchez, Reinhard Klingel, et al.. (2020). Update to the ASFA guidelines on the use of therapeutic apheresis in ANCA‐associated vasculitis. Journal of Clinical Apheresis. 35(5). 493–499. 20 indexed citations
6.
Chong, Elise A., Tahamtan Ahmadi, Nicole A. Aqui, et al.. (2015). Combination of Lenalidomide and Rituximab Overcomes Rituximab Resistance in Patients with Indolent B-cell and Mantle Cell Lymphomas. Clinical Cancer Research. 21(8). 1835–1842. 46 indexed citations
7.
Metjian, Ara, Yvette C. Tanhehco, Huy P. Pham, et al.. (2015). The Thrombotic Microangiopathy Registry of North America. Blood. 126(23). 5587–5587. 3 indexed citations
8.
Metjian, Ara, Yvette C. Tanhehco, Nicole A. Aqui, et al.. (2015). The thrombotic microangiopathy Registry of North America: A United States multi‐institutional TMA network. Journal of Clinical Apheresis. 31(5). 448–453. 7 indexed citations
9.
Sloan, Steven R., Chester Andrzejewski, Nicole A. Aqui, et al.. (2014). Role of therapeutic apheresis in infectious and inflammatory diseases: Current knowledge and unanswered questions. Journal of Clinical Apheresis. 30(5). 259–264. 13 indexed citations
10.
Dolloff, Nathan G., Joshua E. Allen, David T. Dicker, et al.. (2012). Sangivamycin-like Molecule 6 Exhibits Potent Anti-Multiple Myeloma Activity through Inhibition of Cyclin-Dependent Kinase-9. Molecular Cancer Therapeutics. 11(11). 2321–2330. 12 indexed citations
11.
Schuster, Stephen J., Chitra Hosing, Elizabeth J. Shpall, et al.. (2011). Adoptive Immunotherapy with Autologous CD3/CD28-Costimulated T-Cells After Fludarabine-Based Chemotherapy in Patients with Chronic Lymphocytic Leukemia. Blood. 118(21). 2855–2855. 1 indexed citations
12.
13.
Aqui, Nicole A., Leah I. Leinbach, Elise A. Chong, et al.. (2010). Changes in regulatory T-cells in responding and non-responding patients with indolent B-cell or mantle cell lymphomas during treatment with lenalidomide, dexamethasone, and rituximab.. Journal of Clinical Oncology. 28(15_suppl). 8085–8085. 1 indexed citations
14.
Ahmadi, Tahamtan, Elise A. Chong, Amanda Gordon, et al.. (2010). Phase II Trial of Lenalidomide - Dexamethasone - Rituximab In Relapsed or Refractory Indolent B-Cell or Mantle Cell Lymphomas Resistant to Rituximab. Blood. 116(21). 3962–3962. 9 indexed citations
15.
16.
Golovina, Tatiana N., Tatiana Mikheeva, Megan M. Suhoski, et al.. (2008). CD28 Costimulation Is Essential for Human T Regulatory Expansion and Function. The Journal of Immunology. 181(4). 2855–2868. 138 indexed citations
17.
Aqui, Nicole A. & Carl H. June. (2008). Post-transplant adoptive T-cell immunotherapy. Best Practice & Research Clinical Haematology. 21(3). 503–519. 8 indexed citations
18.
Suhoski, Megan M., Tatiana N. Golovina, Nicole A. Aqui, et al.. (2007). Engineering Artificial Antigen-presenting Cells to Express a Diverse Array of Co-stimulatory Molecules. Molecular Therapy. 15(5). 981–988. 208 indexed citations
19.
Aqui, Nicole A., Steven H. Stein, Barbara A. Konkle, Charles S. Abrams, & Frank J. Strobl. (2003). Role of splenectomy in patients with refractory or relapsed thrombotic thrombocytopenic purpura. Journal of Clinical Apheresis. 18(2). 51–54. 35 indexed citations
20.
Aqui, Nicole A., John E. Tomaszewski, David B. P. Goodman, & Donald E. Tsai. (2003). Use of Serum Protein Electrophoresis to Monitor Patients with Post-transplant Lymphoproliferative Disorder. American Journal of Transplantation. 3(10). 1308–1311. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Volker Witt Breakdown of academic impact, for papers by Jan‐Stephan Sanders Breakdown of academic impact, for papers by O. Fain Breakdown of academic impact, for papers by A. Mékinian Breakdown of academic impact, for papers by Maria Greenwald Breakdown of academic impact, for papers by Rob Fijnheer Breakdown of academic impact, for papers by Sonata Jodele Breakdown of academic impact, for papers by Elliot Chartash Breakdown of academic impact, for papers by Laura Connelly‐Smith Breakdown of academic impact, for papers by Kenneth Kalunian
Rankless by CCL
2026